ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

India probes cough syrup linked to Uzbekistan child deaths

Allegations echo Gambia scandal, casting new doubts on 'pharmacy of the world'

Police officers are seen outside a Marion Biotech office in Noida, India, on Dec. 29. Uzbekistan says 18 children died after consuming the company's cough syrup.   © Reuters

NEW DELHI -- India has opened another investigation into cough syrup in response to Uzbekistan's claim that 18 children died after consuming an Indian drugmaker's product, nearly three months after a similar controversy in Gambia.

The Uzbek Health Ministry said this week that 18 out of 21 children known to have taken Dok-1 Max syrup made by India's Marion Biotech had died.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more